Flagship Pioneering: Raised $1.1 billion for its Flagship Labs unit
- Flagship, which raised $1B back in 2019 for growth-stage investment vehicles, develops and operates startups
- In addition to its previous focus on health and sustainability, Flagship will use the new funds to focus on new medicines
- Flagship companies are already on the forefront of the healthcare industry’s efforts to stop the COVID-19 pandemic
- Portfolio company Moderna is one of the companies leading efforts to develop a vaccine for the novel coronavirus
- Flagship has 15 wholly owned companies and another 26 growth-stage companies among its portfolio of investments
- Two of the companies in the Flagship Labs portfolio have already had initial public offerings in the past two years
